The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities

Journal of Medical Economics

Volumn 14, Issue 2, 2011, Pages 253-261

  Dibonaventura, Marco Dacosta ^a   Wagner, Jan Samuel ^a   Yuan, Yong ^b   L'Italien, Gilbert ^b   Langley, Paul ^c   Ray Kim, W ^d  

^a KANTAR HEALTH   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Absenteeism; Employment; Hepatitis C virus; Presenteeism; Work impairment

Indexed keywords

ABSENTEEISM; ADULT; AGED; ARTICLE; COLLEGE; COMORBIDITY; CONTROLLED STUDY; DATA BASE; EMPLOYEE ATTITUDE; EMPLOYMENT STATUS; ETHNICITY; FEMALE; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH INSURANCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCOME; LABOR FORCE PARTICIPATION; MAJOR CLINICAL STUDY; MALE; PRESENTEEISM; PRODUCTIVITY; PROPENSITY SCORE; UNITED STATES; WORK;

ABSENTEEISM; ADAPTATION, PSYCHOLOGICAL; ADULT; CROSS-SECTIONAL STUDIES; EFFICIENCY; EMPLOYMENT; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; RISK FACTORS; STRESS, PSYCHOLOGICAL; UNITED STATES;

EID: 79952997037     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696998.2011.566294     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. Hepatitis C information for the public Retrieved on December 12, 2010: http://www.cdc.gov/hepatitis/C/cFAQ. htm#overview
2. Centers for Disease Control and Prevention. Surveillance for acute viral hep-atitis: United States, 2007. MMWR Surveill Sum 2009;58:SS-3
3. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-14 (Pubitemid 46780630)
4. McHutchison JG, Bacon BR, Owens GS. Making it happen: managed care considerations in vanquishing hepatitis C. Am J Manag Care 2007; 13:S327-36
5. Kim WR. The burden of hepatitis C in the United States. Hepatology 2002; 36(5 Suppl 1):S30-4 (Pubitemid 35253461)
6. Leigh JP, Bowlus CL, Leistikow BN, et al. Costs of hepatitis C. Arch Intern Med 2001;161:2231-7 (Pubitemid 32905004)
7. Wong JB, McQuillan GM, McHutchison JG, et al. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health 2000;90:1562-9
8. Armstrong EP, Charland SL. Burden of illness of hepatitis C from a managed care organization perspective. Curr Med Res Opin 2004;20:671-9 (Pubitemid 38685011)
9. Salomon JA. Weinstein MC, Hammitt JK, et al. Cost-effectiveness of treat-ment for chronic hepatitis C infection in an evolving patient population. JAMA 2003;290:228-37 (Pubitemid 37430062)
10. Jacobs P, Ng YC, Stafinski T, et al. Labour force participation among individ-uals with hepatitis C in the US. Pharmacoeconomics 2003;21:565-72 (Pubitemid 36688100)
11. Montoya ID, Atkinson J, Lichtiger B, et al. Prevalence of hepatitis C in a drug using and non-using welfare population. Health Policy 2003;64:221-8 (Pubitemid 36407677)
12. Su J, Brooks RA, Kleinman NL, et al. The impact of hepatitis C virus on work absence, productivity, and healthcare benefit costs. Hepatology 2010; 52:436-42
13. Perrillo R, Rothstein KD, Rubin R, et al. Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C J Viral Hepat 2004;11:157-65 (Pubitemid 38365767)
14. Lim HJK, Cronkite R, Goldstein MK, et al. The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of life. J Clin Gastroenterol 2006;40:528-34 (Pubitemid 44318138)
15. Kwan JW, Cronkite RC, Yiu A, et al. The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life. Qual Life Res 2008 17:715-24
16. Hauser W, Holtmann G, Grandt D. Determinants of health-related quality of life in patients with chronic liver disease. Clin Gastroenterol Hepatol 2004; 2:157-63 (Pubitemid 38180470)
17. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999;29:264-70 (Pubitemid 29024012)
18. Kallman J, O'Neil MM, Larive B, et al. Fatigueandhealth-relatedqualityof life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci 2007;52:2531-9 (Pubitemid 47373904)
19. Gallegos-Orozco JF, Fuentes AP, Gerado-Argueta J, et al. Health-related quality of life and depression in patients with chronic hepatitis C Arch Med Res 2003;34:124-9 (Pubitemid 36434069)
20. Falasca K, Mancino P, Ucciferri C, et al. Quality of life, depression, and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. Clin Invest Med 2009;32:E212-18
21. DiBonaventura MD, Wagner JS, Yuan Y, et al. Humanistic and economic impacts of hepatitis C infection in the United States. J Med Econ 2010; 13:709-718
22. Bolge SC, Doan JF, Kannan H, et al. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 2009; 18:415-22
23. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics 1993; 4:353-65
24. Gardner W, Mulvey EP, Shaw EC Regression analyses of counts and rates: Poisson, overdispersed poisson, and negative binomial models. Psych Bull 1995;118:392-404
25. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Six Annual SAS-Users Group International Conference, Cary, NC: SAS Institute Inc., 2004;214-26